Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy

被引:26
作者
Proia, LA
Ngui, SL
Kaur, S
Kessler, HA
Trenholme, GM
机构
[1] Rush Presbyterian St Lukes Hosp, Infect Dis Sect, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Hosp, Sect Hepatol, Chicago, IL 60612 USA
关键词
D O I
10.1016/S0002-9343(99)00437-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:249 / 251
页数:3
相关论文
共 10 条
[1]   Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor [J].
Carr, A ;
Cooper, DA .
LANCET, 1997, 349 (9057) :995-996
[2]   Cytotoxic T cells and viral hepatitis [J].
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1472-1477
[3]  
FRENCH M, 1998, 12 WORLD AIDS C GEN
[4]   The treatment of chronic viral hepatitis [J].
Hoofnagle, JH ;
DiBisceglie, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) :347-356
[5]   Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS clinical trials group protocol 315 [J].
Lederman, MM ;
Connick, E ;
Landay, A ;
Kuritzkes, DR ;
Spritzler, J ;
St Clair, M ;
Kotzin, BL ;
Fox, L ;
Chiozzi, H ;
Leonard, JM ;
Rousseau, F ;
Wade, M ;
Roe, JD ;
Martinez, A ;
Kessler, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :70-79
[6]   Hepatitis B virus surface antigen and polymerase gene variants: Potential virological and clinical significance [J].
Locarnini, SA .
HEPATOLOGY, 1998, 27 (01) :294-297
[7]   Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease [J].
Race, EM ;
Adelson-Mitty, J ;
Kriegel, GR ;
Barlam, TF ;
Reimann, KA ;
Letvin, NL ;
Japour, AJ .
LANCET, 1998, 351 (9098) :252-255
[8]  
TORRIANI F, 1998, 12 WORLD AIDS C GEN
[9]  
Vento S, 1998, AIDS, V12, P116
[10]   Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy [J].
Zylberberg, H ;
Pialoux, G ;
Carnot, P ;
Landau, A ;
Bréchot, C ;
Pol, S .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) :1255-1258